Design of sophisticated shaped, multilayered, and multifunctional nanoparticles for combined in-vivo imaging and advanced drug delivery

Design of multifunctional nanoparticles for multimodal in-vivo imaging and advanced targeting to diseased single cells for massive parallel processing nanomedicine approaches requires careful overall design, including particle shape, and a multilayered approach to match the multi-step targeting required. In addition to thermodynamically driven self-assembly, complex patterns can be produced by micro-palette and 3D printing approaches. Initial core materials can include nanomaterials that simultaneously serve as x-ray contrast agents for CAT scan imaging as well as T1 or T2 contrast agents for MRI imaging. Use of superparamagnetic iron oxide allows for convenient magnetic manipulation during manufacturing re-positioning inside the body as well as single-cell hyperthermia therapies. To permit real-time fluorescence-image-guided surgery, fluorescence molecules can also be included. Advanced cell targeting can be achieved by attaching antibodies, peptides, aptamers, or other targeting molecules to the nanoparticle in a multilayered approach mimicking the multi-step targeting required. Addition of “stealth” molecules (e.g. PEG or chitosan) to the outer surfaces of the nanoparticles can permit greatly enhanced circulation times. Nanoscale imaging of these manufactured, multifunctional nanoparticles can be achieved either directly through superresolution microscopy or indirectly through single nanoparticle zeta-sizing or x-ray correlation microscopy. Since these multifunctional nanoparticles are best analyzed by technologies permitting analysis in aqueous environments, superresolution microscopy is, in most cases, the preferred method. This review paper will discuss the importance of specific design criteria as well as advantages and disadvantages of each approach. The overall design required a system engineering approach to the problem.

[1]  Andrew D Ellington,et al.  Construction and selection of bead-bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries designed for rapid PCR-based sequencing. , 2002, Nucleic acids research.

[2]  James F. Leary,et al.  Nanobarcoding: a novel method of single nanoparticle detection in cells and tissues for nanomedical biodistribution studies , 2011, NanoScience + Engineering.

[3]  J. Leary,et al.  Kinetics of virus adsorption to single cells using fluorescent membrane probes and multiparameter flow cytometry , 1982, Cell Biophysics.

[4]  Ick Chan Kwon,et al.  In vivo NIRF and MR dual-modality imaging using glycol chitosan nanoparticles. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[5]  James F. Leary,et al.  Biosensor-controlled gene therapy/drug delivery with nanoparticles for nanomedicine , 2005, SPIE BiOS.

[6]  James F. Leary,et al.  Design of programmable multilayered nanoparticles with in situ manufacture of therapeutic genes for nanomedicine , 2007, SPIE BiOS.

[7]  James F. Leary,et al.  High-throughput flow cytometric screening of combinatorial chemistry bead libraries for proteomics and drug discovery , 2005, SPIE BiOS.

[8]  J. Leary,et al.  Nanobarcoding: detecting nanoparticles in biological samples using in situ polymerase chain reaction , 2012, International journal of nanomedicine.

[9]  J. Leary Chapter 11 Quantitative single-cell approaches to assessing nanotoxicity in nanomedical systems , 2013 .

[10]  James F. Leary,et al.  Nanoparticles, molecular biosensors, and multispectral confocal microscopy , 2004, Journal of Molecular Histology.

[11]  Mouldy Sioud,et al.  Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  Nancy Monteiro-Riviere,et al.  Nanotoxicology: Progress toward Nanomedicine, Second Edition , 2014 .

[13]  Jaehong Key,et al.  Nanoparticles for multimodal in vivo imaging in nanomedicine , 2014, International journal of nanomedicine.

[14]  James F. Leary,et al.  Single-cell imaging detection of nanobarcoded nanoparticle biodistributions in tissues for nanomedicine , 2011, BiOS.

[15]  Xin Li,et al.  Immunofluorescence assay and flow-cytometry selection of bead-bound aptamers. , 2003, Nucleic acids research.

[16]  J. Leary,et al.  Design of Multifunctional Nanomedical Systems , 2009, Annals of Biomedical Engineering.

[17]  James F. Leary,et al.  Dual-modality in vivo imaging for MRI detection of tumors and NIRF-guided surgery using multi-component nanoparticles , 2011, BiOS.

[18]  James F. Leary,et al.  Peptide targeting of quantum dots to human breast cancer cells , 2008, SPIE BiOS.

[19]  J. Leary,et al.  Single-cell nanotoxicity assays of superparamagnetic iron oxide nanoparticles. , 2012, Methods in molecular biology.

[20]  Andreas D. Baxevanis,et al.  The Molecular Biology Database Collection: 2002 update , 2002, Nucleic Acids Res..

[21]  James F. Leary,et al.  Nanomedicine: nanoparticles, molecular biosensors, and targeted gene/drug delivery for combined single-cell diagnostics and therapeutics , 2004, SPIE BiOS.

[22]  James F Leary,et al.  Nanotechnology: what is it and why is small so big? , 2010, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.